相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Autoantibodies in patients with chronic obstructive pulmonary disease
Carol A. Feghali-Bostwick et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Increased activation of p38 MAPK in COPD
T. Renda et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Interleukin-32 monoclonal antibodies for Immunohistochemistry, Western blotting, and ELISA
Ki-Hong Kim et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Endogenous IL-32 controls cytokine and HIV-1 production
Marcel F. Nold et al.
JOURNAL OF IMMUNOLOGY (2008)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary
Klaus F. Rabe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Epithelial overexpression of interleukin-32α in inflammatory bowel disease
M. Shioya et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Antielastin autoimmunity in tobacco smoking-induced emphysema
Seung-Hyo Lee et al.
NATURE MEDICINE (2007)
Update in diffuse parenchymal lung disease 2006
Athol U. Wells et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
IL-32, a novel cytokine with a possible role in disease
C. A. Dinarello et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Mycobacterium tuberculosis induces interleukin-32 production through a caspase1/IL-18/interferon-γ-dependent mechanism
Mihai G. Netea et al.
PLOS MEDICINE (2006)
Up-regulated membrane and nuclear leukotriene B4 receptors in COPD
Emanuela Marian et al.
CHEST (2006)
IL-32, a proinflammatory cytokine in rheumatoid arthritis
LAB Joosten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Chronic obstructive pulmonary disease: current burden and future projections
AD Lopez et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Involvement of IL-32 in activation-induced cell death in T cells
C Goda et al.
INTERNATIONAL IMMUNOLOGY (2006)
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema
F Calabrese et al.
RESPIRATORY RESEARCH (2005)
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema
S Grumelli et al.
PLOS MEDICINE (2004)
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation
HA Fletcher et al.
IMMUNOLOGY (2004)
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
WQ Gan et al.
THORAX (2004)
The nature of small-airway obstruction in chronic obstructive pulmonary disease
JC Hogg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD
A Di Stefano et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Airway inflammation in severe chronic obstructive pulmonary disease -: Relationship with lung function and radiologic emphysema
G Turato et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease
M Saetta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Inflammation of the airways and lung parenchyma in COPD
MG Cosio et al.
CHEST (2002)
Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers
P Maestrelli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Amplification of inflammation in emphysema and its association with latent adenoviral infection
I Retamales et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
J Majo et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Y Kasahara et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)